logo

Alnylam Pharmaceuticals Inc. (ALNY)



Trade ALNY now with
  Date
  Headline
12/10/2018 2:02:07 AM Alnylam Resolves All Litigation Worldwide With Silence Therapeutics
12/6/2018 7:05:19 AM Alnylam Pharma Plans To Discuss Its Pipeline Goals For 2019 At R&D Day
11/26/2018 7:01:38 AM Vir Biotechnology, Alnylam Pharmaceuticals Begin Phase 1/2 Study Of VIR-2218
11/7/2018 8:04:39 AM Alnylam Pharma Q3 Non-GAAP Net Loss $157.3 Mln Or $1.56/shr Vs.net Loss $97.0 Mln Or $1.06/shr Prior Year
10/29/2018 7:32:59 AM Invitae Corp Expands Partnership With Alnylam Pharma To Provide Access To Genetic Testing For Primary Hyperoxaluria
10/15/2018 7:01:02 AM Alnylam Announces Plan To Initiate Rolling Submission Of NDA And Pursue Full Approval For Givosiran
10/10/2018 7:00:53 AM Alnylam Appoints Margaret Hamburg To Board Of Directors
10/4/2018 7:03:56 AM Alnylam Announces Updated Positive Results From Phase 1/2 Clinical Study Of Lumasiran
10/3/2018 7:01:15 AM Alnylam Submits CTA Application For ALN-AAT02
9/28/2018 7:00:59 AM Alnylam Announces Submission Of NDA In Japan For ONPATTRO For Hereditary ATTR Amyloidosis